Fasted Training for Health & Longevity - Quick Reference Sheet

Fasted Training for Health & Longevity

Created on 09/29/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Fasted training, exercise after an overnight fast, is a free scheduling practice shifting fuel use toward body fat, proposed to aid metabolic health. Its best-supported effect is in type 1 diabetes: morning sessions make low blood glucose less likely but high blood glucose afterward more common. Long or hard sessions go worse without food; hunger is stronger; fat-loss claims remain mixed. An optional tool for easy sessions; long-term value uncertain. (Full Review)

Protocol

Standard fasted session
30–60 min easy aerobic
After an 8–12-hour overnight fast; Zone 2, roughly 60–70% of maximal heart rate; only water, black coffee or tea
Frequency
2–4 fasted sessions/week
Within 150–300 minutes of weekly aerobic activity plus two resistance sessions
Periodized "fuel for the work required"
Easy sessions fasted, hard ones fueled
A middle path between fully fasted and fully fed approaches
Time to effect
Glucose in type 1 diabetes
During the session
Glucose rose during fasted morning sessions rather than falling
Insulin sensitivity
After six weeks
Insulin-sensitivity and muscle-enzyme changes appeared after six weeks
Fat use
First session
Fat-use changes occur in the first session

Benefits

Contraindications
  • Hypoglycemia unawareness (no warning symptoms of low glucose) or a severe hypoglycemic episode within the past 3 months
  • Type 1 diabetes with pre-exercise blood ketones at or above 1.5 mmol/L
  • SGLT2 inhibitor users planning fasted sessions longer than 60 minutes
  • Pregnancy
  • Current or past eating disorder, or BMI below 18.5 kg/m²
  • Functional hypothalamic amenorrhea (periods absent 3 months or more)
  • Inherited fatty acid oxidation disorders
  • History of exercise-related syncope (fainting)
  • Athletes before competitions or key sessions longer than 60–90 minutes
Key Interactions
  • Insulin (glargine, lispro, aspart)
  • Sulfonylureas and meglitinides (glipizide, glimepiride, glyburide; repaglinide, nateglinide)
  • SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin)
  • Beta-blockers (metoprolol, propranolol, atenolol)
  • Antihypertensives and diuretics (lisinopril, amlodipine, hydrochlorothiazide, furosemide)
  • GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide)
  • Metformin
  • NSAIDs (ibuprofen, naproxen, aspirin)
  • Over-the-counter stimulants (pseudoephedrine, caffeine tablets)
  • Glucose-lowering supplements (berberine, cinnamon extract, chromium, alpha-lipoic acid)
  • Green tea extract (EGCG)
  • Amino acid supplements (branched-chain and essential amino acids)
  • Other interventions (time-restricted eating, ketogenic diets, prolonged fasts, post-session sauna, evening alcohol in insulin users)

Risk & Side Effects

  • High: Reduced performance in long sessions; post-exercise high blood glucose; increased hunger
  • Medium:
  • Low: Muscle protein breakdown; hypoglycemia with glucose-lowering drugs; slower reaction time after intense efforts
  • Speculative: Intestinal lining stress; low energy availability in women; light-headedness and fainting

Monitoring

Marker Target Why
HbA1c 4.8–5.2% Long-term glucose control
Fasting glucose 75–90 mg/dL (4.2–5.0 mmol/L) Baseline glucose; hypoglycemia margin
Fasting insulin and HOMA-IR Insulin 2–6 µIU/mL; HOMA-IR below 1.0 Tracks insulin sensitivity
Triglycerides Below 100 mg/dL (ideally below 80) Fat handling and metabolic health
Lean and fat mass No established target; stable or rising lean mass vs own baseline Detects muscle loss or fat change
CGM time in range (diabetes) Above 70% at 70–180 mg/dL Captures exercise-related hyperglycemia and hypoglycemia
Blood ketones (beta-hydroxybutyrate) Below 0.6 mmol/L before exercise in type 1 diabetes or SGLT2 use Screens for ketoacidosis risk

Cadence: Baseline before starting; glucose-lowering drug users check glucose before and after each of the first 5–10 fasted sessions, then weekly; type 1 diabetes: review continuous glucose data for 24 hours after each new session type; blood tests at 12 weeks, then every 6–12 months; body composition every 6–12 months.

Qualitative Assessment

  • Energy and perceived effort during sessions at a given pace or power
  • Hunger and cravings in the hours after training
  • Dizziness, shakiness or light-headedness during or after sessions
  • Sleep quality and morning alertness
  • Mood and irritability on training days
  • Menstrual regularity and cycle length in women
  • Recovery and muscle soreness between sessions